Isradipine

In the US, Isradipine (isradipine systemic) is a member of the drug class calcium channel blocking agents and is used to treat Angina Pectoris Prophylaxis, High Blood Pressure and Raynaud's Syndrome.

US matches:

• Isradipine

UK matches:

• ISRADIPINE 2.5 MG TABLETS (Leaflet)
• ISRADIPINE 2.5MG TABLETS (Leaflet)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C08CA03

CAS registry number (Chemical Abstracts Service)

0075695-93-1

Chemical Formula

C19-H21-N3-O5

Molecular Weight

371

Therapeutic Categories

Antihypertensive agent

Calcium channel blocker

Chemical Name

3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimetyl-, metyl 1-metyletyl ester

Foreign Names

• Isradipinum (Latin)
• Isradipin (German)
• Isradipine (French)
• Isradipino (Spanish)

Generic Names

• Isradipine (OS: BAN, DCF, USAN)
• PN 200110 (IS)
• Isradipine (PH: BP 2016, Ph. Eur. 8, USP 38)
• Isradipinum (PH: Ph. Eur. 8)

Brand Names

• Clivoten
  Italfarmaco, Italy
• Dilatol
  Jaba, Portugal
• DynaCirc
  Novartis, Hong Kong; Novartis, Turkey; Novartis AH, South Africa
• DynaCirc CR
  Reliant, United States
• DynaCirc SRO
  Novartis, New Zealand; Novartis, Taiwan
• Esradin
  Sigma-Tau Industrie Farmaceutiche Riunite, Italy
• Icaz
  Daiichi Sankyo, Tunisia
• Icaz LP
  Daiichi Sankyo, France
• Isradipine Actavis
  Actavis, United States
• Lomir
  Daiichi Sankyo, Belgium; Daiichi-Sankyo, Portugal; Novartis, Bangladesh; Novartis, Bahrain; Novartis, Brazil; Novartis, Czech Republic; Novartis, Finland; Novartis, Greece; Novartis, Hungary; Novartis, Lebanon; Novartis, Netherlands; Novartis, Norway; Novartis, Oman; Novartis, Sweden; Novartis, Slovakia
• Lomir Retard
  Daiichi Sankyo, Belgium; Novartis, Denmark; Novartis, Iceland
• Lomir SRO
  2care4, Norway; Daiichi Sankyo, Switzerland; Daiichi Sankyo, Italy; Eureco-Pharma, Netherlands; Euro Registratie, Netherlands; Medcor, Netherlands; Novartis, Czech Republic; Novartis, Hungary; Novartis, Netherlands; Novartis, Norway; Novartis, Finland; Novartis, Sweden; Novartis, Poland
• Prescal
  Novartis Pharmaceuticals UK, United Kingdom
• Vascal uno
  Sanol, Germany; UCB Pharma, Germany
• Vascal uno mite
  Sanol, Germany; UCB Pharma, Germany

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer